ライフサイエンスコーパス: no longer significant

1 e difference in TTP between the two arms was no longer significant.

2 25(OH)D and cardiovascular risk factors were no longer significant.

3 eographic distance, but that relationship is no longer significant.

4 ring PEPFAR's activities, the difference was no longer significant.

5 hen controlling for age, the association was no longer significant.

6 w factors were identified whereas others are no longer significant.

7 99% of the group effect was explained and is no longer significant.

8 lation, but at 72 hrs these differences were no longer significant.

9 iation between TIMI bleeding and outcome was no longer significant.

10 these between-group effects were similar but no longer significant.

11 e SDF1-3'A allele on disease progression was no longer significant.

12 1), whereas the time period of diagnosis was no longer significant.

13 as a percent of daily totals, "cardiac" was no longer significant.

14 When stratified by PAD, this trend was no longer significant.

15 in ASCOT-BPLA, but residual differences were no longer significant.

16 f death for infants born on the weekend were no longer significant.

17 was adjusted for dose/mass, age effects were no longer significant.

18 type 2 diabetes was attenuated and the trend no longer significant.

19 age and weight, the differences in BUA were no longer significant.

20 onse well beyond the time hu5C8 effects were no longer significant.

21 py, the observed benefit of primary PTCA was no longer significant.

22 rence in infection rates analyzed by sex was no longer significant.

23 the difference in in-hospital mortality was no longer significant.

24 death (1.29, 0.84-1.98) were attenuated and no longer significant.

25 children to mothers with bulimia nervosa was no longer significant.

26 diagnosis, overall survival disparities were no longer significant.

27 ntrol condition and the treatment effect was no longer significant.

28 vidual income, while neighborhood income was no longer significant.

29 However, at retention the effect was no longer significant.

30 wever, in multivariate analysis results were no longer significant.

31 g for CFR, the effect of sex on outcomes was no longer significant.

32 However, in the adjusted model, race was no longer significant.

33 After T2, differences between groups were no longer significant.

34 ignificant mediator, while neonatal BVs were no longer significant.

35 tion between BMI and operative mortality was no longer significant.

36 epression severity in citizen scientists was no longer significant.

37 ly updated, associations attenuated and were no longer significant.

38 tance, marital status, and reproduction were no longer significant.

39 9; p <0.001), whereas the effect of LVEF was no longer significant.

40 e 2 groups, the differences in outcomes were no longer significant.

41 cident CVD and cardiovascular mortality were no longer significant.

42 in group; at 30 days, these differences were no longer significant.

43 with viral hepatitis these correlations were no longer significant.

44 adjusted for adiposity, the differences were no longer significant.

45 biomarkers were substantially attenuated and no longer significant.

46 g for multiple subgroups, those results were no longer significant.

47 differences among groups were attenuated and no longer significant.

48 ion frequency and radiological severity were no longer significant.

49 n treatment status, these relationships were no longer significant.

50 ion of race with longer time for listing was no longer significant.

51 l history was included in the model, VDP was no longer significant.

52 ficant, whereas the association for SFAs was no longer significant.

53 ed, except the association with epilepsy was no longer significant.

54 ssociation of tofu with immediate recall was no longer significant.

55 differences in survival between groups were no longer significant.

56 FH and unaffected siblings after 2 years was no longer significant (0.408+/-0.043 and 0.402+/-0.042 m

57 mortality in the participating hospitals was no longer significant (-0.1 percentage points; 95% CI, -

58 the 12-month follow-up, this difference was no longer significant (1.02 [95% CI 0.62-1.66]).

59 r and higher expenses on these measures were no longer significant 12 months after donation.

60 most of these exercise-mediated changes were no longer significant 4 days after exercise.

61 w-up, the difference at 5-year follow-up was no longer significant (53m; 99% CI -225 to 331; p = 0.62

62 0003), but by final follow-up the excess was no longer significant (679/3548 [19.1%] vs 640/3464 [18.

63 low-up, the difference in response rates was no longer significant (69 percent vs. 25 percent, P=0.08

64 4 weeks; the change at 12 months (23.5%) was no longer significant (95% CI -4.5% to 61.6%, p = 0.127)

65 fatigue and odds of having >=3 symptoms were no longer significant across variants.

66 week, although associations with stroke were no longer significant (active WW: 0.89 [95% CI, 0.79-1.0

67 These differences were no longer significant after 12 months.

68 ory subphenotype (OR, 1.6; p = 0.02) but was no longer significant after accounting for bacteremia.

69 lity, but the association was diminished and no longer significant after accounting for individual-le

70 to -0.23) (P = .02), but this difference was no longer significant after accounting for the competing

71 nary artery calcium with type 2 diabetes was no longer significant after adding body mass index to th

72 ated with incident CHF, this association was no longer significant after adding inflammatory markers

73 fidence interval [CI]: 1.15 to 1.72) but was no longer significant after adjusting for behavioral mec

74 These associations were no longer significant after adjusting for birthweight an

75 The difference in C. coccoides was no longer significant after adjusting for BMI and fat in

76 1.75; 95% CI, 1.04-2.94), although this was no longer significant after adjusting for changes in dis

77 oup (2.2%, 1.2%, 0.8%; p < 0.001), which was no longer significant after adjusting for confounding va

78 although these additional associations were no longer significant after adjusting for delayed episod

79 d ARD, 0.71% [95% CI, -0.85% to 2.28%]) were no longer significant after adjusting for dietary choles

80 CI, 1.12-4.01; P = .02); this difference was no longer significant after adjusting for duration of di

81 However, this association was no longer significant after adjusting for financial lite

82 This association was no longer significant after adjusting for hs-TnT (P=0.09

83 ge 3 CKD or higher, but this association was no longer significant after adjusting for obesity, a ris

84 These risks were no longer significant after adjusting for patients' clin

85 and Omicron; however, these differences were no longer significant after adjusting for vaccination st

86 ) on the overdispersion rate was notable but no longer significant after adjusting the effect from se

87 -Bal in the chamber; these associations were no longer significant after adjustment for %EN-WM.

88 This period effect was no longer significant after adjustment for age-related m

89 between statin or aspirin use with IOP were no longer significant after adjustment for beta-blocker

90 ith log CRP levels, but this association was no longer significant after adjustment for BMI and smoki

91 ilon3 group, the genotype effect on risk was no longer significant after adjustment for classic risk

92 osite score: independent of age and sex, but no longer significant after adjustment for education.

93 108.5]; P = .03), but these differences were no longer significant after adjustment for factors relat

94 Sbeta(0) adults, but these associations were no longer significant after adjustment for hemoglobin le

95 cores with maternal fructose consumption was no longer significant after adjustment for maternal SSB

96 had a combined p-value of 0.02 though it was no longer significant after adjustment for multiple test

97 isk of birth defects associated with IVF was no longer significant after adjustment for parental fact

98 However, the association was no longer significant after adjustment for psychiatric s

99 0.001) during long-term follow-up, which was no longer significant after adjustments for baseline cha

100 to 2018 (P for trend = .03); this trend was no longer significant after age adjustment (P for trend

101 ], respectively), but these differences were no longer significant after allowing for sex and body si

102 between tau-PET and plasma GFAP, these were no longer significant after controlling for amyloid-B-PE

103 However, associations were no longer significant after controlling for BMI and pre-

104 over placebo in antidepressant efficacy was no longer significant after controlling for change in ne

105 = .01); but its advantage on neuroticism was no longer significant after controlling for depression (

106 ssociated with exposure during pregnancy was no longer significant after controlling for maternal maj

107 osure to organochlorines and metals but were no longer significant after controlling for sociodemogra

108 es (P < 0.001); however, this difference was no longer significant after controlling for subject-spec

109 h end-tidal alveolar dead space fraction was no longer significant after controlling for the combinat

110 h end-tidal alveolar dead space fraction was no longer significant after controlling for the combinat

111 These were no longer significant after correcting for multiple comp

112 375 mL, respectively; P<0.001), but this was no longer significant after correction for diuretic dose

113 ifferences in femoral artery blood flow were no longer significant after correction for estimated leg

114 n flux in the winter, but these signals were no longer significant after correction for multiple test

115 ted differences in femoral hemodynamics were no longer significant after correction for the influence

116 nominally significant (P = 0.02), they were no longer significant after correction.

117 African Americans (27.8%, p < 0.05) but was no longer significant after further adjustment for body

118 tive hazard, 0.71; P = .02), although it was no longer significant after further adjustment for curre

119 test P=3.03x10(-11)), but the difference was no longer significant after including parental ages in a

120 sity measures to coronary artery calcium was no longer significant after inclusion of apolipoprotein

121 significant in sequenced participants, were no longer significant after multiple testing corrections

122 1.37 (1.14, 1.66)], but the association was no longer significant after multivariable adjustment for

123 e interval, 1.1 to 5.5), the association was no longer significant after multivariable adjustment.

124 idence interval, 1.96.4.0; P<0.0001) but was no longer significant after multivariable adjustment.

125 between GV and mortality for each metric was no longer significant after multivariable adjustment.

126 CI: 1.3-3.4); however, this association was no longer significant after propensity matching (especia

127 ause readmission, but these differences were no longer significant after risk adjustment on 30-day (h

128 ociation of GFR with all-cause mortality was no longer significant after the addition of the filtrati

129 rates decreased with increasing age and was no longer significant after the age of 74 (P< 0.001 for

130 in converters were markedly attenuated (and no longer significant) after adjustment for the homeosta

131 tric slopes for marsupials and eutherians is no longer significant and the slope difference between S

132 at did not receive VC, area differences were no longer significant as all values trended towards zero

133 G and PTCA in costs and quality of life were no longer significant at 10 to 12 years of follow-up.

134 m for DL versus 0.17 mm for IL; P <0.05) was no longer significant at 2 months (0 versus 0.08 mm for

135 However, the difference was no longer significant at 24 weeks, and trial interpretat

136 .1 to 1.9; P=0.02), but this association was no longer significant at 3 months.

137 at 2 months, but the improvement in SFDs was no longer significant at 6 months.

138 This reduction was no longer significant at the 3-year follow-up visit when

139 of asthma between ELBW and NBW children were no longer significant at the age of 14 years (23% vs 17%

140 ing over time such that the relationship was no longer significant by approximately 5 months after AC

141 haemodynamic associations were attenuated or no longer significant, consistent with the hypothesis th

142 blication bias was accounted for, there were no longer significant differences in adherence between a

143 Unlike in earlier years, there are no longer significant differences in outcomes by gender.

144 ke, all intergroup differences for beer were no longer significant; differences for other alcohol sou

145 although the attenuation in inflammation was no longer significant during secondary infection.

146 risk = 15.8, P = 0.02 with aa), while MM was no longer significant (eplet P = 0.56, aa P = 0.51).

147 which were found in the previous study, were no longer significant even when the groups were combined

148 allucinations, although this association was no longer significant following adjustment for intracran

149 s of age, the between-group differences were no longer significant for autoimmunity (21% in group A a

150 death (HR, 1.09; 95% CI, 1.07-1.11) and were no longer significant for ESKD (HR, 1.04; 95% CI, 0.99-1

151 all physicians and ophthalmologists but were no longer significant for family physicians.

152 normal white matter volume, but results were no longer significant for gray matter cerebral blood flo

153 atus, and comorbidities, the association was no longer significant for Hispanics (OR, 0.95; 95% CI, 0

154 prevalence ratios were markedly reduced and no longer significant for men or women.

155 modeled separately, these associations were no longer significant for some CRS subgroups.

156 se factors, difference in survival rates was no longer significant (hazard ratio 0.90 for the second

157 ferences between groups, the association was no longer significant (hazard ratio 0.99; 95% CI 0.77-1.

158 d with MetS was substantially attenuated and no longer significant (hazard ratio 1.14, 95% confidence

159 these associations (except for anxiety) were no longer significant; however, the association with GHQ

160 r multivariate analysis, this difference was no longer significant (HR 1.41; 95% CI 0.88 to 2.27).

161 y measures to the model, the association was no longer significant (HR, 1.10; 95% CI, 0.96-1.26).

162 of BRAF V600E with mortality for all PTC was no longer significant (HR, 1.21; 95% CI, 0.53-2.76).

163 .06), but the association was attenuated and no longer significant in adjusted models (HR = 1.01; 95%

164 However, this relationship was no longer significant in children with PICU stay greater

165 er sensitivity analysis, the PFS benefit was no longer significant in either study (KEYNOTE-361, adju

166 ed confounding; association with outcome was no longer significant in fully adjusted models.

167 This was no longer significant in multivariate models that adjust

168 ficacy of cell therapy on all end points was no longer significant in placebo-controlled randomized c

169 ity and vascular involvement, ulceration was no longer significant in predicting overall survival.

170 0.94]; P = 0.02), but these differences were no longer significant in studies published after 2010 or

171 at the 3- and 6-month follow-ups, which was no longer significant in the long term.

172 However, this association was no longer significant in the modern era (HR 1.14, 95% CI

173 However, this association was no longer significant in the multivariate model (HR 0.86

174 However, these associations were no longer significant in the sibling analyses.

175 inversely associated with eGFR, although was no longer significant in the smaller sensitivity analysi

176 gender, although anxiety and depression were no longer significant independent predictors.

177 parkinsonism was attenuated by >60% and was no longer significant (Lewy bodies: estimate, 0.112; SE,

178 using a random-effects model, the effect was no longer significant (odds ratio, 0.65; 95% CI, 0.25-1.

179 p, with a difference that diminished and was no longer significant on 30 and 90 days.

180 rtant in the cutaneous stages of disease are no longer significant once extracutaneous disease develo

181 t loss because of rejection, this effect was no longer significant once its association with the stro

182 ity at 2 years was evident, this finding was no longer significant once surgeon-specific volume was c

183 sted breast cancer models, associations were no longer significant (OR = 1.06, 95% CI: 0.78, 1.43).

184 perative cholangiography and duct injury was no longer significant (OR, 1.26 [95% CI, 0.81-1.96]; P =

185 es (range FST 0.001-0.019, Nm 12.7-226.1) or no longer significant (P > 0.05) in the case of RST.

186 trast to admission sodium levels, which were no longer significant (p > 0.05).

187 However, these associations were no longer significant (P >= 0.264 for both) after adjust

188 However, these associations were no longer significant (P 0.264 for both) after adjusting

189 s included in the model, this difference was no longer significant (P = .38).

190 um triglycerides, and BMI (P = 0.02) but was no longer significant (P = 0.1) after adjustment for bas

191 P = 0.01) and the HDL-cholesterol effect was no longer significant (P = 0.14).

192 n CFT between the two patients subgroups was no longer significant (p = 0.699).

193 his compound were removed, heterogeneity was no longer significant (P =.58), and the pooled effect si

194 elation between aortic stiffness and GFR was no longer significant (P=0.10).

195 Differences in alveolar bone levels were no longer significant, particularly after introducing th

196 r, risk for subjective memory impairment was no longer significant (RR [95% CI]: 1.18 [0.95-1.47], p

197 ychological scores at baseline, results were no longer significant (RR: 1.09; 95% CI: 0.99, 1.21; P-t

198 e slope of the relation between PK and U was no longer significant, so that PK was no longer flow dep

199 2015 to 2017 compared with 2000 to 2002 was no longer significant (standardized risk ratios for canc

200 operator volume and in-hospital mortality is no longer significant, the relationship between volume a

201 1.0 to 1.55]); however, this association was no longer significant when accounting for air pollution.

202 =0.06), the relative risk for graft loss was no longer significant when additionally adjusted for ind

203 This association was no longer significant when adjusted for age and sex.

204 rtners aged 35-49 years, although the OR was no longer significant when adjusted for HIV status of pa

205 se in %SFA and decrease in triglycerides was no longer significant when adjusting for 12-month change

206 However, this association was no longer significant when adjusting for SES indicators

207 However, this effect was no longer significant when age was included as a covaria

208 However, these associations were no longer significant when analyses were adjusted for ei

209 depression/CRP and executive functioning was no longer significant when controlling for these covaria

210 exploring emotion portrayed, however, it was no longer significant when exploring modality and intens

211 alth insurance literacy, the association was no longer significant when financial literacy was added

212 This association was no longer significant when intraoperative/postoperative

213 However, many associations were no longer significant when limited to trials at low risk

214 were attenuated and, for common carotid IMT, no longer significant when lipids, hypertension, diabete

215 osed group, but the association with AKI was no longer significant when models were adjusted for thre

216 However, this relationship was no longer significant when only examining full mutation,

217 ed for primary tumor size (P = 0.03) but was no longer significant when stratified for disease status

218 The increase of triacylglycerols was no longer significant when studies with the highest risk

219 These associations were no longer significant when the analysis was restricted t

220 erences in REE were reduced by >50% and were no longer significant when the mass of specific high-met

221 hysical abuse's effect on SI variability was no longer significant, when controlling for the effect o

222 in concentrations and neutrophil counts were no longer significant, whereas differences in platelet,

223 ler magnitude than in the overall cohort and no longer significant, whereas in the ROW subgroup, the

224 tiviral transcriptional control pathways was no longer significant with adjustment for depressive sym

225 nd comorbidities however, the difference was no longer significant with an odds ratio of 1.11 (95% co

226 bo, but these effects were less apparent and no longer significant with application of more stringent

227 fter randomization, but this association was no longer significant with longer follow-up.

228 effect of micrometastases decreased and was no longer significant, with a hazard ratio of 1.09 (0.74